Core Scientific (CORZ) Cost of Revenue (2021 - 2026)

Core Scientific (CORZ) has 6 years of Cost of Revenue data on file, last reported at $85.1 million in Q1 2026.

• Quarterly Cost of Revenue rose 19.39% year-over-year to $85.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $294.9 million (down 17.9% YoY) and the FY2025 annual result came in at $281.1 million, down 27.84% from the prior year.
• Cost of Revenue rose to $85.1 million in Q1 2026 per CORZ's latest filing, from $59.0 million in the prior quarter.
• The five-year high for Cost of Revenue was $375.8 million in Q4 2023, with the low at -$450.7 million in Q4 2022.
• Average Cost of Revenue over 5 years is $57.3 million, with a median of $77.2 million recorded in 2025.
• Year-over-year, Cost of Revenue tumbled 219.34% in 2022 and jumped 9335.89% in 2024.
• Core Scientific's Cost of Revenue stood at -$450.7 million in 2022, then jumped by 183.39% to $375.8 million in 2023, then sank by 76.01% to $90.2 million in 2024, then plunged by 34.55% to $59.0 million in 2025, then surged by 44.28% to $85.1 million in 2026.
• Business Quant data shows CORZ's Cost of Revenue at $85.1 million in Q1 2026, $59.0 million in Q4 2025, and $77.2 million in Q3 2025.